422 related articles for article (PubMed ID: 25822790)
1. Two disparate ligand-binding sites in the human P2Y1 receptor.
Zhang D; Gao ZG; Zhang K; Kiselev E; Crane S; Wang J; Paoletta S; Yi C; Ma L; Zhang W; Han GW; Liu H; Cherezov V; Katritch V; Jiang H; Stevens RC; Jacobson KA; Zhao Q; Wu B
Nature; 2015 Apr; 520(7547):317-21. PubMed ID: 25822790
[TBL] [Abstract][Full Text] [Related]
2. Distinct Signaling Patterns of Allosteric Antagonism at the P2Y
Gao ZG; Jacobson KA
Mol Pharmacol; 2017 Nov; 92(5):613-626. PubMed ID: 28864555
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Different Agonist-Binding Site and Activation Mechanism of the Human P2Y
Li Y; Yin C; Liu P; Li D; Lin J
Sci Rep; 2017 Oct; 7(1):13764. PubMed ID: 29062134
[TBL] [Abstract][Full Text] [Related]
4. BPTU, an allosteric antagonist of P2Y1 receptor, blocks nerve mediated inhibitory neuromuscular responses in the gastrointestinal tract of rodents.
Mañé N; Jiménez-Sábado V; Jiménez M
Neuropharmacology; 2016 Nov; 110(Pt A):376-385. PubMed ID: 27496690
[TBL] [Abstract][Full Text] [Related]
5. Agonist-bound structure of the human P2Y12 receptor.
Zhang J; Zhang K; Gao ZG; Paoletta S; Zhang D; Han GW; Li T; Ma L; Zhang W; Müller CE; Yang H; Jiang H; Cherezov V; Katritch V; Jacobson KA; Stevens RC; Wu B; Zhao Q
Nature; 2014 May; 509(7498):119-22. PubMed ID: 24784220
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
[TBL] [Abstract][Full Text] [Related]
7. The Molecular Mechanism of P2Y1 Receptor Activation.
Yuan S; Chan HC; Vogel H; Filipek S; Stevens RC; Palczewski K
Angew Chem Int Ed Engl; 2016 Aug; 55(35):10331-5. PubMed ID: 27460867
[TBL] [Abstract][Full Text] [Related]
8. Demystifying P2Y
Ciancetta A; O'Connor RD; Paoletta S; Jacobson KA
J Chem Inf Model; 2017 Dec; 57(12):3104-3123. PubMed ID: 29182323
[TBL] [Abstract][Full Text] [Related]
9. Quantification of recombinant and platelet P2Y(1) receptors utilizing a [(125)I]-labeled high-affinity antagonist 2-iodo-N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([(125)I]MRS2500).
Ohlmann P; de Castro S; Brown GG; Gachet C; Jacobson KA; Harden TK
Pharmacol Res; 2010 Oct; 62(4):344-51. PubMed ID: 20594939
[TBL] [Abstract][Full Text] [Related]
10. Structure of the human P2Y12 receptor in complex with an antithrombotic drug.
Zhang K; Zhang J; Gao ZG; Zhang D; Zhu L; Han GW; Moss SM; Paoletta S; Kiselev E; Lu W; Fenalti G; Zhang W; Müller CE; Yang H; Jiang H; Cherezov V; Katritch V; Jacobson KA; Stevens RC; Wu B; Zhao Q
Nature; 2014 May; 509(7498):115-8. PubMed ID: 24670650
[TBL] [Abstract][Full Text] [Related]
11. [32P]2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([32P]MRS2500), a novel radioligand for quantification of native P2Y1 receptors.
Houston D; Ohno M; Nicholas RA; Jacobson KA; Harden TK
Br J Pharmacol; 2006 Mar; 147(5):459-67. PubMed ID: 16299552
[TBL] [Abstract][Full Text] [Related]
12. Blockade of peripheral P2Y1 receptors prevents the induction of thermal hyperalgesia via modulation of TRPV1 expression in carrageenan-induced inflammatory pain rats: involvement of p38 MAPK phosphorylation in DRGs.
Kwon SG; Roh DH; Yoon SY; Moon JY; Choi SR; Choi HS; Kang SY; Han HJ; Beitz AJ; Lee JH
Neuropharmacology; 2014 Apr; 79():368-79. PubMed ID: 24333674
[TBL] [Abstract][Full Text] [Related]
13. The synthesis and initial characterization of an immobilized purinergic receptor (P2Y1) liquid chromatography stationary phase for online screening.
Moaddel R; Calleri E; Massolini G; Frazier CR; Wainer IW
Anal Biochem; 2007 May; 364(2):216-8. PubMed ID: 17391632
[No Abstract] [Full Text] [Related]
14. Diadenosine tetraphosphate activates P2Y
Paquola A; Mañé N; Giron MC; Jimenez M
Eur J Pharmacol; 2019 Jul; 855():160-166. PubMed ID: 31063775
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide P2Y
Liston TE; Hinz S; Müller CE; Holstein DM; Wendling J; Melton RJ; Campbell M; Korinek WS; Suresh RR; Sethre-Hofstad DA; Gao ZG; Tosh DK; Jacobson KA; Lechleiter JD
Purinergic Signal; 2020 Dec; 16(4):543-559. PubMed ID: 33129204
[TBL] [Abstract][Full Text] [Related]
16. ATP P2Y1 receptors control cognitive deficits and neurotoxicity but not glial modifications induced by brain ischemia in mice.
Carmo MR; Simões AP; Fonteles AA; Souza CM; Cunha RA; Andrade GM
Eur J Neurosci; 2014 Feb; 39(4):614-22. PubMed ID: 24304101
[TBL] [Abstract][Full Text] [Related]
17. GPR17: molecular modeling and dynamics studies of the 3-D structure and purinergic ligand binding features in comparison with P2Y receptors.
Parravicini C; Ranghino G; Abbracchio MP; Fantucci P
BMC Bioinformatics; 2008 Jun; 9():263. PubMed ID: 18533035
[TBL] [Abstract][Full Text] [Related]
18. Ligand binding to a G protein-coupled receptor captured in a mass spectrometer.
Yen HY; Hopper JTS; Liko I; Allison TM; Zhu Y; Wang D; Stegmann M; Mohammed S; Wu B; Robinson CV
Sci Adv; 2017 Jun; 3(6):e1701016. PubMed ID: 28630934
[TBL] [Abstract][Full Text] [Related]
19. The Molecular Mechanism Underlying Ligand Binding to the Membrane-Embedded Site of a G-Protein-Coupled Receptor.
Yuan X; Raniolo S; Limongelli V; Xu Y
J Chem Theory Comput; 2018 May; 14(5):2761-2770. PubMed ID: 29660291
[TBL] [Abstract][Full Text] [Related]
20. 2-Aminothiazole based P2Y(1) antagonists as novel antiplatelet agents.
Pi Z; Sutton J; Lloyd J; Hua J; Price L; Wu Q; Chang M; Zheng J; Rehfuss R; Huang CS; Wexler RR; Lam PY
Bioorg Med Chem Lett; 2013 Jul; 23(14):4206-9. PubMed ID: 23743287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
